Resource Library

Product Introduction/Implementation Project Planning for Next-Generation PrEP

Early data from clinical trials has indicated that Cabotegravir (CAB) for PrEP is safe and effective. With an accelerated timeline for introduction of CAB for PrEP, AVAC and WHO convened a think tank to strategize about demonstration projects and other planning for product introduction.

HIV Testing and Injectable Cabotegravir (CAB for PrEP) Introduction: What are the implications for HIV prevention scale-up and the HIV response?

One challenge which has emerged with the introduction of CAB for PrEP is the risk of Integrase Strand Transfer Inhibitor (INSTI) resistance amongst people who acquire HIV while taking CAB as prescribed. To address emerging evidence around testing algorithms and INSTI resistance in CAB users, AVAC and WHO convened a think tank with program implementers,…

Testing

Stakeholder conversations to inform delivery of multiple HIV prevention methods in Kenya

This report highlights findings from stakeholder conversations implemented in Kenya as part of the PROMISE Collaboration to gain input on implementation considerations for the introduction of the PrEP ring alongside oral PrEP and future inclusion of additional prevention methods for women

Research, Service Delivery

Prevention Options for Women Evaluation Research (POWER) Formative Work Report – August 2017

This is a formative work report on the POWER Study, which aimed to characterize choice, uptake, and early adherence to PrEP, and sought to identify cost-effective and scalable delivery models to young women in Kenya and South Africa.

Research

Prevention Options for Women Evaluation Research Key Informant Interviews Qualitative Report – July 2020

This is a report on Key Informant Interviews undertaken for the POWER Study, which aimed to characterize choice, uptake, and early adherence to PrEP, and sought to identify cost-effective and scalable delivery models to young women in Kenya and South Africa.

Research

Digital Health Landscaping Report

This landscape analysis aimed to identify common virtual channels used in several countries, estimate the number of users of each channel, and categorize countries into one of three groups based on potential for interventions to use virtual channels to succeed. Users were defined as adolescent girls and young women (aged 15–24), pregnant or breastfeeding people…

Demand Creation/Marketing, Service Delivery

Proposed New National-level Indicators for M&E for all forms of PrEP

A series of think tanks brought together PrEP experts to reflect on lessons learned from oral PrEP rollout and how those could applied to provide more meaningful measures of program performance for all forms of PrEP.

Monitoring & Evaluation

Evaluating, Scaling up and Enhancing Strategies for Supporting PrEP Continuation and Effective Use

The Prevention Product Manager (PMM) a joint partnership between AVAC and the Clinton Health Access Initiative (CHAI) and Jhpiego convened think tanks to discuss options for defining and measuring PrEP continuation. Recommendations from the think tank included modifications to current PrEP indicators, recognizing that a single definition of correct or effective use might not be…

Research, Monitoring & Evaluation, Service Delivery

PrEP for Pregnant and Breastfeeding People: Implementation Guide (English)

Implementation Guide: Providing PrEP to Pregnant and Breastfeeding People: A Training Manual for Health Care Workers

Normative Guidance/Policies, Service Delivery

Guidance for the Use of Pre-exposure Prophylaxis (PrEP) for the Prevention of HIV Acquisition in British Columbia

These guidelines were developed by the British Columbia Centre for Excellence in HIV/AIDS and focus on the provision of PrEP as a part of a comprehensive approach to combination prevention, drawing on implementation and research evidence and WHO recommendations.

Normative Guidance/Policies